NASDAQ:JKSM Jacksam (JKSM) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free JKSM Stock Alerts $0.01 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.0070▼$0.010250-Day Range$0.01▼$0.0252-Week Range$0.01▼$0.03Volume258,090 shsAverage Volume38,269 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsSocial Media Get Jacksam alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About JacksamJacksam Corporation, doing business as Convectium, focuses on developing and commercializing products of vaporizer cartridge filling and capping, pre-roll filling, and other automation systems. Its products include 710 Shark cartridge filling machines, 710 Captain cartridge capping machines, PreRoll-ER pre-roll and cone filling machines, and C-Cell cartridges. The company markets and sells its products to medical and recreational dispensaries, large and small-scale processors and growers, multi-state operators, and distributors through direct sales force, independent sales representatives, strategic partners' sales force, and a referral network, as well as its Website. It serves the medical and recreational cannabis, hemp, and CBD segments of the e-cigarette, vaporizer, and pre-roll markets. The company was founded in 2013 and is based in Costa Mesa, California.Read More JKSM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart JKSM Stock News HeadlinesFebruary 17, 2024 | morningstar.comRevive Therapeutics Ltd RVVTFNovember 17, 2023 | finance.yahoo.comRichtech Robotics Inc. Class B Common Stock (RR)April 28, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.January 25, 2023 | finance.yahoo.comJacksam Corporation (JKSM) Stock Historical Prices & Data - Yahoo FinanceSeptember 17, 2022 | reuters.comJKSM.PK - Jacksam Corp | Stock Price & Latest News | ReutersAugust 16, 2022 | finanznachrichten.deJacksam Corp.: Jacksam Corporation Reports Return to Adjusted EBITDA Breakeven in the Second Quarter 2022August 16, 2022 | finance.yahoo.comJacksam Corporation Reports Return to Adjusted EBITDA Breakeven in the Second Quarter 2022May 17, 2022 | finanznachrichten.deJacksam Corp.: Jacksam Corporation Reports First Quarter 2022 Revenue of $1.8 Million with Positive EBITDA and Net IncomeApril 28, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.May 17, 2022 | finance.yahoo.comJacksam Corporation Reports First Quarter 2022 Revenue of $1.8 Million with Positive EBITDA and Net IncomeApril 4, 2022 | finance.yahoo.comJacksam Corporation Announces 2021 Financial Results Highlighted by 106% Revenue Growth to $6.7 MillionNovember 12, 2021 | finance.yahoo.comJacksam Corporation dba Convectium Continues Strong Growth Trajectory And Announces Fiscal 2021 Third Quarter Results Highlighted By 165% Y/Y Growth And Operating ProfitabilityOctober 20, 2021 | finance.yahoo.comJacksam Corporation dba Convectium Further Diversifies into Flower and Enters the Infused Pre-Roll MarketAugust 12, 2021 | finance.yahoo.comJacksam Corporation dba Convectium Announces Fiscal 2021 Second Quarter Results Highlighted by 162% Y/Y GrowthSee More Headlines Receive JKSM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Jacksam and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/16/2024Today4/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorIndustrials Industry Specialty Industrial Machinery Sub-IndustryN/A Current SymbolNASDAQ:JKSM CUSIPN/A CIK860543 Webjacksamcorp.com Phone(800) 605-3580FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Mark Adams (Age 55)Interim CFO, President, CEO & Director Comp: $120kMr. Brett MackerVP of OperationsMr. David HallExecutive VP of SalesKey CompetitorsNature's MiracleNASDAQ:NMHIWShapewaysNASDAQ:SHPWWADS-TEC EnergyNASDAQ:ADSEWAeries TechnologyNASDAQ:AERTWAir TNASDAQ:AIRTPView All Competitors JKSM Stock Analysis - Frequently Asked Questions How have JKSM shares performed in 2024? Jacksam's stock was trading at $0.0240 at the beginning of the year. Since then, JKSM stock has decreased by 57.3% and is now trading at $0.0102. View the best growth stocks for 2024 here. How were Jacksam's earnings last quarter? Jacksam Co. (NASDAQ:JKSM) issued its earnings results on Tuesday, April, 16th. The company reported ($0.01) EPS for the quarter. The business earned $0.23 million during the quarter. What other stocks do shareholders of Jacksam own? Based on aggregate information from My MarketBeat watchlists, some companies that other Jacksam investors own include Invictus MD Strategies (IVITF), Organigram (OGI), SinglePoint (SING), Unrivaled Brands (TRTC), Aethlon Medical (AEMD), EGF Theramed Health (EVAHF), EVIO (EVIO), SOL Global Investments (SOLCF) and How do I buy shares of Jacksam? Shares of JKSM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:JKSM) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jacksam Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
